Cargando…

Type 1 diabetes patient experiences and management practices during the COVID-19 pandemic in rural Uganda

BACKGROUND: The COVID-19 pandemic has impacted various aspects of the lives of persons with chronic diseases, including type 1 diabetes (T1D). However, the diabetes care experiences and practices adopted by persons living with T1D after the declaration of the COVID-19 pandemic in Uganda have not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Sseguya, Wenceslaus, James, Steven, Bwambale, Manfred, L Klatman, Emma, D Ogle, Graham, Munyagwa, Mary, Maniam, Jayanthi, Wesonga, Ronald, Bahendeka, Silver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201465/
https://www.ncbi.nlm.nih.gov/pubmed/37363199
http://dx.doi.org/10.1007/s40200-023-01222-4
Descripción
Sumario:BACKGROUND: The COVID-19 pandemic has impacted various aspects of the lives of persons with chronic diseases, including type 1 diabetes (T1D). However, the diabetes care experiences and practices adopted by persons living with T1D after the declaration of the COVID-19 pandemic in Uganda have not been well documented. OBJECTIVES: We investigated diabetes management practices and experiences of persons with T1D during the COVID-19 pandemic lockdown in a rural district of southwestern Uganda. METHODS: Using interactive sequential explanatory mixed methods, we conducted a cross-sectional study of persons with T1D aged 18–25 years, their caregivers and health workers. Quantitative data was exclusively collected from patients with T1D using Kobo Toolbox™ and analysed with SPSS™ version 26; qualitative interviews were used to elicit responses from purposively selected patients with T1D, plus caregivers and health workers that were analysed using a thematic framework approach. RESULTS: The study enrolled 51 (24 males) patients with T1D; diabetes duration (mean ± SD) 6.6 ± 5 years. Access to insulin syringes significantly worsened in 19.6% of participants (p = 0.03). Insulin injection frequency (p = 0.01), blood glucose monitoring (p = 0.001) and meal frequency (p = 0.0001) significantly decreased. Qualitative interviews highlighted COVID-19 restriction measures had reduced household income, frequency of clinic visits, and access to food, diabetes support and social services. CONCLUSIONS: Experiences and practices were consistent with decisions to prioritise survival, even with known risks around metabolic control. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40200-023-01222-4.